Physician profile
Constants Adams
NPI 1508307810
$1,315.90
in general payments reported to CMS, 2019-2025
17 companies · $481 in 2025
The $481 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $226 · 2023: $80.74 · 2024: $267 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.64 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $151.28 | 2021-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $141.47 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Myovant Sciences INC. | $132.86 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.95 | 2023-2025 | |
| Organon LLC | $108.76 | 2021-2025 | Nexplanon |
| Biogen, INC. | $103.10 | 2025 | Zurzuvae |
| Pfizer INC. | $78.88 | 2024-2025 | |
| Astellas Pharma US INC | $47.28 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $42.56 | 2024 | Slynd |
| Aspira Women'S Health INC | $35.40 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $29.71 | 2024 | |
| Seqirus USA INC | $22.90 | 2024 | Flucelvax, Fluad |
| Exact Sciences Corporation | $22.71 | 2025 | The Cologuard Plus Collection Kit |
| Gynesonics, INC. | $17.92 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $16.83 | 2025 | Intrarosa |
| Channel Medsystems, INC. | $14.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constants Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.